Skip to content

Evaluation of postoperative nausea and vomiting prevention by comparing Granisetron and Palonosetron in adult patients undergoing laparoscopic surgery.

COMPARISON OF GRANISETRON AND PALANOSETRON FOR PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN ADULT PATIENTS UNDERGOING LAPAROSCOPIC SURGERY.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036824
Enrollment
80
Registered
2021-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Control Intervention1: Granisetron and Palonosetron: Preoperatively just before induction of anaesthesia group A patients will be given single dose of Palonosetron 1mcg/kg and group B patients single

Sponsors

ABVIMS and Dr Ram Manohar Lohia Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing laparoscopic surgery. ASA grade - 1 and 2 .

Exclusion criteria

Exclusion criteria: 1) Patient having history of motion sickness or past history of PONV 2) Opioid dependence 3) Pregnant females 4) Patients with liver diseases 5) Patients receiving chemotherapy or radiotherapy within the past four weeks. 6) Use of antiemetic drugs within 24 hours prior to surgery. 7) Allergy to any drug used in the study. 8) Patients taking drug which increases serotonin release like selective serotonin reuptake inhibitors ( citalopram, fluoxetine, paroxetine)

Design outcomes

Primary

MeasureTime frame
Incidence of post operative nausea and vomiting in the first 24 hours following conclusion of anaesthesia Timepoint: In first 24 hours

Secondary

MeasureTime frame
1) Requirement of rescue antiemetic. 2) Overall satisfaction of patient with nausea and vomiting experience. 3) Occurence of adverse effects like headache, dizziness, drowsiness, injection site pain or reaction etc.Timepoint: After 24 hours

Countries

India

Contacts

Public ContactPriyanka Singh

ABVIMS and Dr RML Hospital

nishakachru@yahoo.co.uk9810488435

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026